JP2022525706A5 - - Google Patents
Info
- Publication number
- JP2022525706A5 JP2022525706A5 JP2022504738A JP2022504738A JP2022525706A5 JP 2022525706 A5 JP2022525706 A5 JP 2022525706A5 JP 2022504738 A JP2022504738 A JP 2022504738A JP 2022504738 A JP2022504738 A JP 2022504738A JP 2022525706 A5 JP2022525706 A5 JP 2022525706A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pain
- pharmaceutical composition
- composition according
- isomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1903900.7A GB2582361A (en) | 2019-03-21 | 2019-03-21 | Adenosine receptor agonists |
| GB1903900.7 | 2019-03-21 | ||
| PCT/GB2020/050734 WO2020188288A1 (en) | 2019-03-21 | 2020-03-19 | Adenosine receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525706A JP2022525706A (ja) | 2022-05-18 |
| JP2022525706A5 true JP2022525706A5 (https=) | 2023-03-27 |
Family
ID=66381433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022504738A Pending JP2022525706A (ja) | 2019-03-21 | 2020-03-19 | アデノシン受容体アゴニスト |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220152077A1 (https=) |
| EP (1) | EP3941482A1 (https=) |
| JP (1) | JP2022525706A (https=) |
| GB (1) | GB2582361A (https=) |
| WO (1) | WO2020188288A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113082020A (zh) * | 2021-04-08 | 2021-07-09 | 徐州医科大学 | 一种腺苷受体激动剂的增强剂及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK62692D0 (https=) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| GB9930075D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| GB9930085D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| GB9930079D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| WO2005117910A2 (en) * | 2004-05-26 | 2005-12-15 | Inotek Pharmaceuticals Corporation | Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| WO2011011919A1 (zh) * | 2009-07-31 | 2011-02-03 | 新道生技股份有限公司 | 一种降血糖的组合物 |
| JP2013523738A (ja) * | 2010-03-26 | 2013-06-17 | イノテック ファーマシューティカルズ コーポレイション | アデノシン化合物およびそれらの使用 |
| WO2017137528A1 (en) * | 2016-02-12 | 2017-08-17 | Charité - Universitätsmedizin Berlin | Adenosine a1 receptor agonist for use in treatment of status epilepticus |
-
2019
- 2019-03-21 GB GB1903900.7A patent/GB2582361A/en not_active Withdrawn
-
2020
- 2020-03-19 WO PCT/GB2020/050734 patent/WO2020188288A1/en not_active Ceased
- 2020-03-19 EP EP20715187.9A patent/EP3941482A1/en not_active Withdrawn
- 2020-03-19 JP JP2022504738A patent/JP2022525706A/ja active Pending
- 2020-03-19 US US17/441,257 patent/US20220152077A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6089045B2 (ja) | 痛みの緩和または治療に使用するためのフェニルカルバメート化合物 | |
| JP2021105032A5 (https=) | ||
| JP2013139446A5 (https=) | ||
| JP2023508469A5 (https=) | ||
| RU2003128535A (ru) | Гетерополициклическое соединение (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, ассоциированного с активацией метаботропных глютаматных рецепторов (варианты) | |
| JP2008520589A5 (https=) | ||
| RU2009124541A (ru) | Тозилатная соль терапевтического соединения и ее фармацевтические композиции | |
| CN1235579C (zh) | 用于预防或治疗神经变性疾病的氨基甲酸酯化合物 | |
| JP2022515293A5 (https=) | ||
| TWI389873B (zh) | 阿戈美拉汀（ａｇｏｍｅｌａｔｉｎｅ）之新晶形iii，其製備方法及包含其之醫藥組合物 | |
| JP2024504252A5 (https=) | ||
| JP2022539152A5 (https=) | ||
| JP2011525185A5 (https=) | ||
| JP2019529460A5 (https=) | ||
| JP2019516756A5 (https=) | ||
| FI3956310T3 (fi) | Modifioituja aminohappojohdannaisia neurologisten sairauksien ja valittujen psykiatristen häiriöiden hoitamiseksi | |
| JP2021534227A5 (https=) | ||
| JP2022525706A5 (https=) | ||
| JP2016537432A5 (https=) | ||
| JP2014518552A5 (https=) | ||
| JP2022512373A5 (https=) | ||
| JP2019535715A5 (https=) | ||
| JP2006511604A5 (https=) | ||
| JP5341037B2 (ja) | 双極性障害を処置するための医薬を得るためのアゴメラチンの使用 | |
| RU2019102757A (ru) | Производные этинила |